+91-8668442535

Continuous Renal Replacement Therapy Market By Product (Systems, Consumables), By Modality (Continuous Veno-Venous Hemodiafiltration (CVVHDF), Continuous Veno-Venous Hemodialysis (CVVHD), Continuous Veno-Venous Hemofiltration (CVVH), Slow Continuous Ultrafiltration (SCUF), Therapeutic Plasma Exchange (TPE) ) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

Acute renal failure is a sudden loss of renal function that may be reversible depending on the cause and severity of the condition. Acute renal failure is a common complication of critical illness and ICU admission. Mortality associated with ARF is high, with approximately 50% of patients dying. Continuous renal replacement therapy is a type of hemodialysis that was innovated by medical practitioners facing the restrictions of peritoneal dialysis and the delays in beginning intermittent hemodialysis. Transporting patients to a dialysis unit for treatment puts their health at risk and delays necessary treatment. With the additional advantage of having user-friendly equipment and better solute removal, CRRT has become widely adopted and appropriately suited for treatment in acute renal failure.

The purpose of this research study titled "Continuous Renal Replacement Therapy Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global continuous renal replacement therapy market. This report presents and analyses the major trends prevalent in the global market for continuous renal replacement therapy, as well as the market's size and forecast.

This report categorizes the global continuous renal replacement therapy market in terms of products, modality, and geographical distribution. Based on product type, the global continuous renal replacement therapy market is categorized into systems and consumables. The consumables segment is further studied for filters, tubing sets, and disposables. Additionally, continuous venovenous hemodiafiltration (CVVHDF), continuous venovenous hemodialysis (CVVHD), continuous venovenous hemofiltration (CVVH), slow continuous ultrafiltration (SCUF), and therapeutic plasma exchange (TPE) are the dialysis modalities considered for the purpose of this study. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

Geographically, the global market for continuous renal replacement therapy is best understood by segmenting it into five major regions and five major region-level markets, as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of the Middle East and Africa

The market size and forecast of each considered geographical market are presented for the period 2015–2025, along with CAGRs for the forecast period 2017–2025, and further cross-sectional analysis is presented in terms of product type, modality, and constituent region or country-level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global continuous renal replacement therapy market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the continuous renal replacement therapy market. The key players profiled in this report are Asahi Kasei Corporation, Baxter International Inc., B. Braun Melsungen AG, BeLLCo S.R.L. (Medtronic PLC), Fresenius Medical Care AG & Co. KGaA, Medica SpA, Medites Pharma spol. Sro., NxStage Medical, Inc., NIPRO Corporation, SWS Hemodialysis Care Co., Ltd., and Toray Medical Co., Ltd.

The global market for continuous renal replacement therapy is being studied for its application in the following products for the purposes of this study:

  • Systems
  • Consumables
  • Filters
  • Tubing Sets
  • Disposables

Consumables currently occupy the larger revenue share in the global continuous renal replacement treatment market. Large purchase orders of consumables and disposables and regular demand for these products mainly contribute to the dominance of these products. Some of the most common consumable products in the market for continuous renal replacement therapy are filters, hemofilter, absorbent materials, tubing systems, needles, and others. With the growing rate of hospitalization, it is anticipated that the demand for CRRT devices and consumables will rise correspondingly with the incidence of acute renal failure. It is further observed that the demand for CRRT systems will be consistent with the forecast. However, due to the rapid evolution of healthcare infrastructure and rising healthcare expenditure in the regions, demand for these devices will be higher than the global benchmark in emerging markets such as Latin America and Asia Pacific.

The global market for continuous renal replacement therapy is studied for the following modalities:

  • Continuous Veno-Venous Hemodiafiltration (CVVHDF)
  • Continuous Veno-Venous Hemodialysis (CVVHD)
  • Continuous Veno-Venous Hemofiltration (CVVH)
  • Slow Continuous Ultrafiltration (SCUF)
  • Therapeutic Plasma Exchange (TPE)

Continuous venovenous hemofiltration currently enjoys dominance in the global market for continuous renal replacement therapy. This modality operates on the same principle as slow continuous ultrafiltration (the removal of excess fluid from the body); however, the filter used in CVVH has a larger pore size. Such filtered fluid is thereafter replaced with fluid with suitable chemistry for normal blood. This mode uses convection. Therefore, it is suitable for removing molecules of varied sizes depending on the size of the filter pores. It is expected that the demand for continuous venovenous hemofiltration will witness notable growth during the forecast. This CRRT modality is a combination of ultrafiltration, convection, and diffusion to enable the optimum replacement of fluids and solutes in the blood.

The global market for continuous renal replacement therapy is geographically divided into North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.

North America, comprising the country-level markets of the U.S. and Canada, is the largest regional market for continuous renal replacement therapy. The key growth contributors in the North American market are the high prevalence of acute renal diseases, increased adoption of novel filtration systems, and a better reimbursement system. Greater awareness and a significant prevalence of chronic diseases leading to admissions to the ICU also drive the North American market for continuous renal replacement therapy. On the other hand, it is expected that the Asia-Pacific market will witness the fastest growth on the global front. Increasing awareness in the general population and among physicians, a rapid rise in the number of hospitals due to the evolution of healthcare infrastructure, and rising healthcare expenditures of the general patient population are expected to drive the Asia Pacific continuous renal replacement therapy market.

The detailed regional classification of the global continuous renal replacement therapy market is as follows:

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, and the Rest of Europe)
  • Asia Pacific (China, Japan, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (including the Gulf Cooperation Council and the rest of the Middle East and Africa) 

Frequently Asked Questions:

The market for Continuous Renal Replacement Therapy is expected to reach US$ 1,653.8 Mn in 2025.

The Continuous Renal Replacement Therapy market is expected to see significant CAGR growth over the coming years,at 7.47%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Asahi Kasei Corporation,Baxter International Inc.,B.Braun Melsungen AG,BeLLCo S.R.L. (Medtronic PLC),Fresenius Medical Care AG & Co. KGaA are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Sep 2017
Category:  Medical Devices
Report ID:   58700
Report Format:   PDF
Pages:   120
Rating:    4.7 (80)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support